Phosphate Binders Show Similar Efficacy in African Americans
Study compared sucroferric oxyhydroxide and sevelamer carbonate.
Kidney Week 2015 Hyperphosphatemia
CKD-MBD May Play Role in Restless Legs Syndrome in Dialysis Patients
Phosphate and vitamin D deficiency were linked with RLS severity.
CKD Severity Linked to Low BMD, Hip Fracture, and Mortality
The risk of dying following a hip fracture was 6.5 times higher for patients with severe CKD than for those with normal kidney function or mild CKD.
High Phosphate Increases Mortality Risk in CKD Patients
Meta-analysis finds that each 1 mg/dL increase in serum phosphate increases the risk of death by 23%.
High Phosphorus, Cerebral Hemorrhage Linked in HD Patients
Researchers observe a 2.2-fold increased risk in patients with serum phosphate levels of 6.0 mg/dL or higher.
Low Magnesium Ups Cardiovascular Death Risk
Study finds a 42% increased risk of death from coronary heart disease and 68% increased risk of sudden cardiac death.
Sucroferric Oxyhydroxide Reduces Phosphorus, Binder Pill Burden
Researchers observe a significant mean decrease in binder pills from 8.4 to 3.8 pills per day.
HD Patients with Lowest FGF-23 Level Have Lowest Survival Rate
Cumulative 2-year survival rate was 65.4%, 78.9%, 85.1%, and 80.6% among patients in the 1st, 2nd, 3rd, and 4th quartiles.
Stopping Cinacalcet for Non-Medical Reasons Ups Death Risk
About 3 additional deaths per 100 persons occur when the drug is discontinued due to non-medical versus medical reasons during the first year.
Ferric Citrate Reduces Hyperphosphate, EPO Requirement
Significant decreases in serum phosphate and erythropoietin dose in hemodialysis patients observed after 6 months of treatment.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Kidney Week 2015 Hyperphosphatemia
Loading... 
Loading...